Mankind Pharma Ltd (MANKIND) — Financial Flexibility Index
Mankind Pharma Ltd (MANKIND) has a Financial Flexibility Index of 0.08x as of September 2023. Free cash flow of Rs1.93 Billion (operating CF Rs1.93 Billion minus capex Rs0.00) represents 0% of total liabilities (Rs24.65 Billion). Also explore MANKIND shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mankind Pharma Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Mankind Pharma Ltd across 7 annual periods. Check Mankind Pharma Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Mankind Pharma Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for Mankind Pharma Ltd. For the full company profile including market capitalisation, see Mankind Pharma Ltd (MANKIND) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | Rs28.74 Billion | Rs24.13 Billion | Rs131.91 Billion | ▼ -79.5% |
| 2024 | 1.06x | Rs25.35 Billion | Rs21.52 Billion | Rs23.87 Billion | ▼ -17.1% |
| 2023 | 1.28x | Rs26.45 Billion | Rs18.13 Billion | Rs20.67 Billion | ▲ +11.0% |
| 2022 | 1.15x | Rs32.65 Billion | Rs9.20 Billion | Rs28.31 Billion | ▲ +20.1% |
| 2021 | 0.96x | Rs14.50 Billion | Rs11.37 Billion | Rs15.10 Billion | ▲ +3.7% |
| 2020 | 0.93x | Rs12.98 Billion | Rs10.70 Billion | Rs14.02 Billion | ▲ +16.6% |
| 2019 | 0.79x | Rs8.98 Billion | Rs6.00 Billion | Rs11.31 Billion | — |